Guideline on Chinese Medicine Rehabilitation for Idiopathic Pulmonary Fibrosis

被引:0
作者
Jian-Sheng Li
Ming-Hang Wang
Yang Xie
机构
关键词
D O I
暂无
中图分类号
R259 [现代医学内科疾病];
学科分类号
100506 ;
摘要
<正>Foreword Note: Some of the elements of this document may be the subject of patent rights. WFCMS shall not be held responsible for identifying any or all such patent rights.Main drafting organizations: Henan University of Chinese Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine.
引用
收藏
页码:475 / 484
页数:10
相关论文
共 22 条
[1]  
Pulmonary Daoyin as a traditional Chinese medicine rehabilitation programme for patients with IPF: A randomized controlled trial.[J] Zhou Miao;Zhang Hailong;Li Fenglei;Yu Zhefeng;Yuan Chengbo;Oliver Brian;Li Jiansheng Respirology (Carlton; Vic.) 2020,
[2]  
Guidelines for Chinese medicine rehabilitation of chronic obstructive pulmonary disease[J] Jian-Sheng Li World Journal of Traditional Chinese Medicine 2020,
[3]  
A randomized controlled clinical study of acupuncture therapy for Seborrheic alopecia in young and middle ages: Study protocol clinical trial (SPIRIT compliant).[J] Chen Qiulian;Tao Yun;Wang Longjun;Zhang Jinfang;Sun Bichen;Yang Xiaoli Medicine 2020,
[4]  
Trends in Idiopathic Pulmonary Fibrosis-related Mortality in the United States: 2000-2017.[J] Dove Erik P;Olson Amy L;Glassberg Marilyn K American journal of respiratory and critical care medicine 2019,
[5]  
The Mortality Burden of Idiopathic Pulmonary Fibrosis in the United Kingdom.[J] Navaratnam Vidya;Hubbard Richard B American journal of respiratory and critical care medicine 2019,
[6]  
Idiopathic Pulmonary Fibrosis: Epidemiology; Diagnosis andOutcomes[J] Yosafe Wakwaya;Kevin K. Brown The American Journal of the Medical Sciences 2019,
[7]  
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.[J] Raghu Ganesh;Remy-Jardin Martine;Myers Jeffrey L;Richeldi Luca;Ryerson Christopher J;Lederer David J;Behr Juergen;Cottin Vincent;Danoff Sonye K;Morell Ferran;Flaherty Kevin R;Wells Athol;Martinez Fernando J;Azuma Arata;Bice Thomas J;Bouros Demosthenes;Brown Kevin K;Collard Harold R;Duggal Abhijit;Galvin Liam;Inoue Yoshikazu;Jenkins R Gisli;Johkoh Takeshi;Kazerooni Ella A;Kitaichi Masanori;Kni
[8]  
Idiopathic pulmonary fibrosis.[J] Martinez Fernando J;Collard Harold R;Pardo Annie;Raghu Ganesh;Richeldi Luca;Selman Moises;Swigris Jeffrey J;Taniguchi Hiroyuki;Wells Athol U Nature reviews. Disease primers 2017,
[9]  
An evaluation of activity tolerance; patient-reported outcomes and satisfaction with the effectiveness of pulmonary daoyin on patients with chronic obstructive pulmonary disease.[J] Zhang Hai-Long;Li Jian-Sheng;Yu Xue-Qing;Li Su-Yun;Halmurat Upur;Xie Yang;Wang Yan-Fang;Li Feng-Sen;Wang Ming-Hang International journal of chronic obstructive pulmonary disease 2017,
[10]  
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.[J] Hutchinson John;Fogarty Andrew;Hubbard Richard;McKeever Tricia The European respiratory journal 2015,